Literature DB >> 20789265

Carcinomatous Syndromes.

.   

Abstract

Entities:  

Year:  1961        PMID: 20789265      PMCID: PMC1970248     

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  12 in total

1.  Neurological syndromes associated with carcinoma: the carcinomatous neuromyopathies.

Authors:  R BRAIN; R A HENSON
Journal:  Lancet       Date:  1958-11-08       Impact factor: 79.321

2.  The syndrome of intrathoracic neoplasia with bilateral hyperfunction of the adrenal cortex.

Authors:  A G HILLS; K A WOEBER
Journal:  Ann Intern Med       Date:  1961-06       Impact factor: 25.391

3.  Dermatomyositis and malignancy: a review of the literature.

Authors:  R C WILLIAMS
Journal:  Ann Intern Med       Date:  1959-05       Impact factor: 25.391

4.  Thrombophlebitis and cancer.

Authors:  J S LIEBERMAN; J BORRERO; E URDANETA; I S WRIGHT
Journal:  JAMA       Date:  1961-08-26       Impact factor: 56.272

5.  Carcinoma and Cushing's syndrome.

Authors: 
Journal:  Br Med J       Date:  1961-08-19

6.  Acute disseminated demyelination of the brain associated with lymphosarcoma.

Authors:  O C LLOYD; H URICH
Journal:  Lancet       Date:  1959-10-10       Impact factor: 79.321

7.  The significance of nonbacterial thrombotic endocarditis: an autopsy and clinical study of 78 cases.

Authors:  R A MACDONALD; S L ROBBINS
Journal:  Ann Intern Med       Date:  1957-02       Impact factor: 25.391

8.  Polycythemia and renal carcinoma.

Authors:  A DAMON; D A HOLUB; M M MELICOW; A C USON
Journal:  Am J Med       Date:  1958-08       Impact factor: 4.965

9.  Bronchial neoplasm with myasthenia; prolonged apnoea after administration of succinylcholine.

Authors:  H J ANDERSON; H C CHURCHILL-DAVIDSON; A T RICHARDSON
Journal:  Lancet       Date:  1953-12-19       Impact factor: 79.321

10.  Idiopathic neuropathy in cancer. A first sign in multiple system syndromes associated with malignancy.

Authors:  G W HOLT
Journal:  Am J Med Sci       Date:  1961-07       Impact factor: 2.378

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.